A last-minute deal on prescription drugs, unresolved issues on climate change, taxes, paid leave and immigration.
Now the question is what exactly the agreement entails — and what it would mean for the American people.
No reforms would be a major setback for Democrats, a big victory for the drug industry — and a loss for millions who need help with their prescription costs.
The Arizona senator says her role model is John McCain, who relished attacking the drug industry.
A deal on prescription drugs may be closer than it seems, although the big question is what would be in it.
It depends on whether Manchin cares about the bill's sheer ambition or just its increase in federal spending.
It's a lot of money, but still less than the Great Society — and still not what they spend in Europe.
Corporate donations, not electoral fears, appear to be motivating obstructionist Democrats.
This week’s infrastructure fiasco was only a preview of the coming fight.
Rep. Jake Auchincloss’ objection to a key element of Democrats' prescription drug bill shines a light on the pharmaceutical industry’s enduring influence on Capitol Hill.
Aduhelm, a pricey treatment meant to stall mental decline, may be a case study in everything that's wrong with how America manages prescription drugs.
It's popular, they've done the work and even pharma loses once in a while.
The administration is bypassing Congress and trying to rush the cards to seniors, with Election Day just weeks away. Can they really do that?
A nonprofit's new website and ad campaign spotlights former pharmaceutical executives now holding top administration positions.
Other 2020 hopefuls including Amy Klobuchar, Kirsten Gillibrand and Elizabeth Warren have proposed measures to clamp down on the pharmaceutical industry.
Dr. Steven R. Henson was convicted of prescribing what a judge described as “massive amounts of opioids ... with little demonstrated need.”
Trump Administration Brags About Quick Generic Drug Approvals. But Hundreds Of Them Aren’t For Sale.
Meanwhile, brand-name drug makers are raising prices at 10 percent per year.
As the feds crack down on opioid prescriptions, patients are taking their own lives, doctors are losing their jobs and overdose rates continue unabated.
It's common for addicts to turn to new and old addictions this time of year, but there are ways to help.
Florida Blue will stop covering the painkiller in an effort to stem substance abuse.